flumazenil has been researched along with Liver Cirrhosis, Alcoholic in 6 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Liver Cirrhosis, Alcoholic: FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In animal studies as well as in a few cases in humans, the benzodiazepine antagonist flumazenil has been shown to reverse hepatic encephalopathy." | 7.68 | [Treatment of acute hepatic encephalopathy with flumazenil]. ( Bassoul, B; de La Coussaye, JE; Eledjam, JJ; Saissi, G; Viel, E, 1990) |
| "In animal studies as well as in a few cases in humans, the benzodiazepine antagonist flumazenil has been shown to reverse hepatic encephalopathy." | 3.68 | [Treatment of acute hepatic encephalopathy with flumazenil]. ( Bassoul, B; de La Coussaye, JE; Eledjam, JJ; Saissi, G; Viel, E, 1990) |
| " Consequently, it could be anticipated that hepatic disease affects the elimination and oral bioavailability of flumazenil." | 2.66 | Flumazenil disposition and elimination in cirrhosis. ( Janssen, U; Klotz, U; Maier, K; von Gaisberg, U; Walker, S, 1989) |
| "He was treated for hepatic encephalopathy with complete recovery and resolution of the neurologic findings." | 2.46 | Reversible hepatic decerebration: a case report and review of the literature. ( Antoun, SA; Delgado, F; Saad, D; Ta, H; Wehbe, E, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wehbe, E | 1 |
| Saad, D | 1 |
| Delgado, F | 1 |
| Ta, H | 1 |
| Antoun, SA | 1 |
| Kapczinski, F | 2 |
| Sherman, D | 1 |
| Williams, R | 1 |
| Lader, M | 1 |
| Curran, V | 1 |
| Amaral, OB | 1 |
| Quevedo, J | 1 |
| Walz, R | 1 |
| Viel, E | 1 |
| de La Coussaye, JE | 1 |
| Bassoul, B | 1 |
| Saissi, G | 1 |
| Eledjam, JJ | 1 |
| Janssen, U | 1 |
| Walker, S | 2 |
| Maier, K | 1 |
| von Gaisberg, U | 1 |
| Klotz, U | 2 |
1 review available for flumazenil and Liver Cirrhosis, Alcoholic
| Article | Year |
|---|---|
Reversible hepatic decerebration: a case report and review of the literature.
Topics: Alcoholism; Decerebrate State; Flumazenil; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Alcoholi | 2010 |
3 trials available for flumazenil and Liver Cirrhosis, Alcoholic
| Article | Year |
|---|---|
Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients.
Topics: Adult; Anxiety; Female; Flumazenil; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Funct | 1995 |
Flumazenil disposition and elimination in cirrhosis.
Topics: Administration, Oral; Adult; Biological Availability; Chemical Phenomena; Chemistry; Clinical Trials | 1989 |
Flumazenil and hepatic encephalopathy.
Topics: Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Flumazenil; Hepatic Encephalopathy; | 1989 |
2 other studies available for flumazenil and Liver Cirrhosis, Alcoholic
| Article | Year |
|---|---|
Flumazenil and hepatic encephalopathy.
Topics: Benzodiazepines; Flumazenil; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoh | 1999 |
[Treatment of acute hepatic encephalopathy with flumazenil].
Topics: Acute Disease; Flumazenil; Glasgow Coma Scale; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Alco | 1990 |